Mascini E M, Jansze M, Verhoef J, van Dijk H
Eijkman-Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, University Medical Center, Utrecht, The Netherlands.
Clin Diagn Lab Immunol. 1999 Nov;6(6):977-80. doi: 10.1128/CDLI.6.6.977-980.1999.
In this pilot study, we investigated the relative avidities for streptococcal pyrogenic exotoxin A (SPE-A) and SPE-B of antibodies in sera from patients with fatal streptococcal toxic shock-like syndrome and from healthy individuals and in intravenous immunoglobulin (IVIG) preparations. We observed a great variation in the relative avidities of patient, control, and IVIG immunoglobulin G (IgG) (values estimated to be between 10(-7) and 10(-11) M), with mean values for patient IgG about 10-fold lower than those of control IgG.
在这项初步研究中,我们调查了致命性链球菌中毒性休克样综合征患者及健康个体血清中的抗体以及静脉注射免疫球蛋白(IVIG)制剂对链球菌致热外毒素A(SPE-A)和SPE-B的相对亲和力。我们观察到患者、对照及IVIG免疫球蛋白G(IgG)的相对亲和力存在很大差异(估计值在10^(-7)至10^(-11) M之间),患者IgG的平均值比对照IgG低约10倍。